Literature DB >> 17025259

Influence of hydrophilic polymers on celecoxib complexation with hydroxypropyl beta-cyclodextrin.

Kora Pattabhi Ramaiah Chowdary1, Sekuboyina Vijaya Srinivas.   

Abstract

Complexation of celecoxib with hydroxypropyl beta-cyclodextrin (HPbetaCD) in the presence and absence of 3 hydrophilic polymers-polyvinyl pyrrolidone (PVP), hydroxypropyl methylcellulose (HPMC), and polyethylene glycol (PEG)-was investigated with an objective of evaluating the effect of hydrophilic polymers on the complexation and solubilizing efficiencies of HPbetaCD and on the dissolution rate of celecoxib from the HPbetaCD complexes. The phase solubility studies indicated the formation of celecoxib-HPbetaCD inclusion complexes at a 1:1M ratio in solution in both the presence and the absence of hydrophilic polymers. The complexes formed were quite stable. Addition of hydrophilic polymers markedly enhanced the complexation and solubilizing efficiencies of HPbetaCD. Solid inclusion complexes of celecoxib-HPbetaCD were prepared in 1:1 and 1:2 ratios by the kneading method, with and without the addition of hydrophilic polymers. The solubility and dissolution rate of celecoxib were significantly improved by complexation with HPbetaCD. The celecoxib-HPbetaCD (1:2) inclusion complex yielded a 36.57-fold increase in the dissolution rate of celecoxib. The addition of hydrophilic polymers also markedly enhanced the dissolution rate of celecoxib from HPbetaCD complexes: a 72.60-, 61.25-, and 39.15-fold increase was observed with PVP, HPMC, and PEG, respectively. Differential scanning calorimetry and X-ray diffractometry indicated stronger drug amorphization and entrapment in HPbetaCD because of the combined action of HPbetaCD and the hydrophilic polymers.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17025259      PMCID: PMC2750521          DOI: 10.1208/pt070379

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  14 in total

1.  Cyclodextrin Drug Carrier Systems.

Authors:  Kaneto Uekama; Fumitoshi Hirayama; Tetsumi Irie
Journal:  Chem Rev       Date:  1998-07-30       Impact factor: 60.622

2.  Industrial Applications of Cyclodextrins.

Authors:  Allan R. Hedges
Journal:  Chem Rev       Date:  1998-07-30       Impact factor: 60.622

Review 3.  Celecoxib and rofecoxib. The role of COX-2 inhibitors in dental practice.

Authors:  P A Moore; E V Hersh
Journal:  J Am Dent Assoc       Date:  2001-04       Impact factor: 3.634

Review 4.  Celecoxib for the treatment of pain and inflammation: the preclinical and clinical results.

Authors:  E Tindall
Journal:  J Am Osteopath Assoc       Date:  1999-11

Review 5.  Pharmaceutical applications of cyclodextrins. 2. In vivo drug delivery.

Authors:  R A Rajewski; V J Stella
Journal:  J Pharm Sci       Date:  1996-11       Impact factor: 3.534

Review 6.  Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization.

Authors:  T Loftsson; M E Brewster
Journal:  J Pharm Sci       Date:  1996-10       Impact factor: 3.534

Review 7.  Update on clinical developments with celecoxib, a new specific COX-2 inhibitor: what can we expect?

Authors:  G S Geis
Journal:  Scand J Rheumatol Suppl       Date:  1999

Review 8.  Celecoxib, a COX-2--specific inhibitor: the clinical data.

Authors:  J Fort
Journal:  Am J Orthop (Belle Mead NJ)       Date:  1999-03

Review 9.  Celecoxib: a new option in the treatment of arthropathies and familial adenomatous polyposis.

Authors:  N M Davies; T W Gudde; M A de Leeuw
Journal:  Expert Opin Pharmacother       Date:  2001-01       Impact factor: 3.889

10.  Beta-cyclodextrin complexes of celecoxib: molecular-modeling, characterization, and dissolution studies.

Authors:  M Narender Reddy; Tasneem Rehana; S Ramakrishna; K P R Chowdhary; P V Diwan
Journal:  AAPS PharmSci       Date:  2004-03-05
View more
  5 in total

1.  In vitro and in vivo evaluation of proniosomes containing celecoxib for oral administration.

Authors:  Mohamed Nasr
Journal:  AAPS PharmSciTech       Date:  2010-01-08       Impact factor: 3.246

Review 2.  Advanced technologies for oral controlled release: cyclodextrins for oral controlled release.

Authors:  Paulo José Salústio; Patrícia Pontes; Claúdia Conduto; Inês Sanches; Catarina Carvalho; João Arrais; Helena M Cabral Marques
Journal:  AAPS PharmSciTech       Date:  2011-09-27       Impact factor: 3.246

3.  Improved Aqueous Solubility and Antihypercholesterolemic Activity of Ezetimibe on Formulating with Hydroxypropyl-β-Cyclodextrin and Hydrophilic Auxiliary Substances.

Authors:  Kale Mohana Raghava Srivalli; Brahmeshwar Mishra
Journal:  AAPS PharmSciTech       Date:  2015-06-16       Impact factor: 3.246

4.  Effect of auxiliary substances on complexation efficiency and intrinsic dissolution rate of gemfibrozil-beta-CD complexes.

Authors:  Fareen Sami; Betty Philip; Kamla Pathak
Journal:  AAPS PharmSciTech       Date:  2009-12-15       Impact factor: 3.246

5.  Improvement of solubility and dissolution properties of clotrimazole by solid dispersions and inclusion complexes.

Authors:  Gehan Balata; M Mahdi; Rania Abu Bakera
Journal:  Indian J Pharm Sci       Date:  2011-09       Impact factor: 0.975

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.